Technical Analysis for ATOWW - Atossa Genetics Inc. - Warrants [24/05/2021]

Grade Last Price % Change Price Change
grade F 0.25 -16.67% -0.0500
ATOWW closed down 16.67 percent on Tuesday, December 31, 2019, on 15 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical ATOWW trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -16.67%
Stochastic Reached Oversold Weakness -16.67%
Wide Bands Range Expansion -16.67%
Oversold Stochastic Weakness -16.67%
Narrow Range Bar Range Contraction -16.67%
Wide Bands Range Expansion -16.67%
Older signals for ATOWW ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Atossa Genetics Inc. a clinical-stage pharmaceutical company, focuses on the development and sale of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions in the United States. The company is conducting a Phase 2 clinical study using microcatheters to deliver fulvestrant as a potential treatment of ductal carcinoma in situ and breast cancer; and a pharmaceutical program under development is Endoxifen, an active metabolite of tamoxifen, as well as treatment for breast density and other breast health conditions. It offers ForeCYTE Breast Aspirator and FullCYTE Breast Aspirator, which collects specimens of nipple aspirate fluid (NAF)for cytological testing at a laboratory; and a transport kit to assist with the packaging and transport of NAF samples to a laboratory, as well as manufactures and sells various medical devices primarily consisting of tools to assist breast surgeons. Atossa Genetics Inc. was founded in 2009 and is headquartered in Seattle, Washington.
RTT Drugs Pharmaceutical Breast Cancer Medical Devices Endocrine System Hormones Astrazeneca Treatment Of Breast Cancer

Is ATOWW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 3.1
52 Week Low 0.01
Average Volume 27,775
200-Day Moving Average 0.0000
50-Day Moving Average 0.6701
20-Day Moving Average 0.7845
10-Day Moving Average 0.5390
Average True Range 0.4108
ADX 24.93
+DI 22.4977
-DI 36.5863
Chandelier Exit (Long, 3 ATRs ) 0.7676
Chandelier Exit (Short, 3 ATRs ) 1.2424
Upper Bollinger Band 1.4526
Lower Bollinger Band 0.1164
Percent B (%b) 0.1
BandWidth 170.3250
MACD Line -0.1224
MACD Signal Line -0.0365
MACD Histogram -0.0859
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2500
Resistance 3 (R3) 0.2500 0.2500 0.2500
Resistance 2 (R2) 0.2500 0.2500 0.2500 0.2500
Resistance 1 (R1) 0.2500 0.2500 0.2500 0.2500 0.2500
Pivot Point 0.2500 0.2500 0.2500 0.2500 0.2500
Support 1 (S1) 0.2500 0.2500 0.2500 0.2500 0.2500
Support 2 (S2) 0.2500 0.2500 0.2500 0.2500
Support 3 (S3) 0.2500 0.2500 0.2500
Support 4 (S4) 0.2500